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AbsTrACT
Introduction HIV- exposed uninfected children may be 
at risk of poor neurodevelopment. We aimed to test the 
impact of improved infant and young child feeding (IYCF) 
and improved water, sanitation and hygiene (WASH) on 
early child development (ECD) outcomes.
Methods Sanitation Hygiene Infant Nutrition Efficacy 
was a cluster randomised 2×2 factorial trial in rural 
Zimbabwe  ClinicalTrials. gov NCT01824940). Pregnant 
women were eligible if they lived in study clusters 
allocated to standard- of- care (SOC; 52 clusters); IYCF 
(20 g small- quantity lipid- based nutrient supplement/
day from 6 to 18 months, complementary feeding 
counselling; 53 clusters); WASH (pit latrine, 2 hand- 
washing stations, liquid soap, chlorine, play space, 
hygiene counselling; 53 clusters) or IYCF +WASH 
(53 clusters). Participants and fieldworkers were 
not blinded. ECD was assessed at 24 months using 
the Malawi Developmental Assessment Tool (MDAT; 
assessing motor, cognitive, language and social skills); 
MacArthur Bates Communication Development Inventory 
(assessing vocabulary and grammar); A- not- B test 
(assessing object permanence) and a self- control task. 
Intention- to- treat analyses were stratified by maternal 
HIV status.
results Compared with SOC, children randomised 
to combined IYCF +WASH had higher total MDAT 
scores (mean difference +4.6; 95% CI 1.9 to 7.2) and 
MacArthur Bates vocabulary scores (+8.5 words; 
95% CI 3.7 to 13.3), but there was no evidence of 
effects from IYCF or WASH alone. There was no 
evidence that that any intervention impacted object 
permanence or self- control.
Conclusions Combining IYCF and WASH interventions 
significantly improved motor, language and cognitive 
development in HIV- exposed children.
Trial registration number NCT01824940.
InTroduCTIon
Globally, 1.4 million HIV- infected women 
become pregnant each year, predominantly 
in sub- Saharan Africa. Due to increased 
Key questions
What is already known?
 ► Globally, an estimated 43% of children fail to reach 
their full developmental potential.
 ► The population of HIV- exposed uninfected (HEU) chil-
dren is expanding, and reached nearly 15 million in 
2017.
 ► Children who are HEU may be at greater risk of 
poor early child development than HIV- unexposed 
children.
What are the new findings?
 ► Compared with standard- of- care, children ran-
domised to combined infant and young child feeding 
(IYCF) plus water, sanitation and hygiene (WASH) had 
higher total child development scores as measured 
by the Malawi Developmental Assessment Tool 
(mean difference +4.6; 95% CI 1.9 to 7.2).
 ► Compared with standard- of- care, children ran-
domised to combined IYCF+WASH had higher 
MacArthur Bates vocabulary scores (+8.5 words; 
95% CI 3.7 to 13.3).
 ► There was no evidence that IYCF or WASH alone af-
fected child development.
What do the new findings imply?
 ► HEU children may be particularly responsive to a 
package of public health interventions, which may 
support a targeted intervention approach to ensure 
that HEU children survive, thrive and reach their full 
potential.
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coverage of prevention of mother- to- child transmission 
(PMTCT) interventions, the number of HIV- exposed 
uninfected (HEU) children is expanding, and reached 
nearly 15 million in 2017.1 HEU children have higher 
mortality and more frequent and more severe infections, 
anaemia and growth faltering than children born to 
HIV- negative mothers (HIV- unexposed children).2 Since 
stunting (linear growth faltering),3 anaemia4 and inflam-
mation5 are all associated with impaired neurodevelop-
ment, HEU children may be at greater risk of poor early 
child development (ECD) than HIV- unexposed chil-
dren, although empirical evidence is limited.6 Together 
these observations suggest that interventions to reduce 
stunting, anaemia and infections may have particular 
benefits for the growing population of HEU children, 
including enhanced neurodevelopment.
The Sanitation Hygiene Infant Nutrition Efficacy 
(SHINE) trial was designed to assess the individual and 
combined effects of an infant and young child feeding 
(IYCF) intervention and a household water, sanitation 
and hygiene (WASH) intervention on stunting and 
anaemia in HIV- unexposed and HIV- exposed Zimba-
bwean children.7 The WASH intervention was designed 
to reduce exposure to faecal microbes, and thereby 
prevent a subclinical inflammatory disorder of the gut 
termed environmental enteric dysfunction (EED), 
which may mediate stunting, anaemia and reduced 
ECD. We previously reported that the IYCF interven-
tion reduced stunting and anaemia in HIV- unexposed8 
and HIV- exposed9 children at 18 months of age, but the 
WASH intervention had no impact on either of these 
trial outcomes. A substudy, assessing the effects of the 
randomised interventions on ECD at 24 months of age, 
showed there was overall little impact of either interven-
tion on neurodevelopment among HIV- unexposed chil-
dren.10 Here, we report the impact of the randomised 
interventions on ECD at 24 months among HIV- exposed 
children, in whom we hypothesised the trial interventions 
may have distinct effects compared with HIV- unexposed 
children.
MeTHods
 study design and randomisation
The SHINE trial design has been reported previously; 
the protocol and statistical analysis plan are available 
at https:// osf. io/ w93hy Briefly, SHINE was a cluster 
randomised, community- based 2×2 factorial trial 
conducted in two contiguous rural districts in Zimbabwe. 
Clusters were defined as the catchment area of 1–4 village 
health workers (VHWs) employed by the Ministry of 
Health and Child Care, and were allocated to one of four 
treatment groups (standard- of- care (SOC), IYCF, WASH, 
IYCF +WASH) at a public randomisation event. A highly 
constrained randomisation technique achieved balance 
across arms for 14 variables related to geography, demog-
raphy, water access and sanitation coverage. Between 22 
November 2012 and 27 March 2015, VHWs identified 
pregnant women and referred them to trial research 
nurses, who enrolled women permanently residing in 
the study area into SHINE following written informed 
consent. HIV prevalence among antenatal women in the 
study area was 15%; we prespecified that analysis of all 
outcomes would be stratified by maternal HIV status.
Trial interventions
Interventions were informed by extensive formative 
research and piloting.7 Behavioural change modules 
using interactive tools to deliver specific messages were 
provided by arm- specific VHWs; lesson plans and inter-
vention tools are publicly accessible at https:// osf. io/ 
w93hy. All women were scheduled to receive 15 VHW 
visits between enrolment and 12 months postpartum; 
other family members were encouraged to participate. 
At each visit, previous information was reviewed before 
introducing new information to create a sequenced, inte-
grated, longitudinal intervention. Between 13 and 17 
months, VHWs visited monthly, providing routine care 
and, in active arms, delivering intervention supplies; 
during these visits VHWs informally encouraged partic-
ipants to practise relevant behaviours. At 18 months, a 
review module was delivered in all arms. Key messages and 
supplies are outlined below, with more detail provided in 
the online supplementary methods:
 ► SOC Promotion of exclusive breast feeding to 6 
months, uptake of antenatal and neonatal care, 
PMTCT, immunisations, family planning.
 ► IYCF All SOC messages plus (1) importance of nutri-
tion for infant health, growth and development; (2) 
feeding nutrient- dense food and 20 g small- quantity 
lipid- based nutrient supplement (SQ- LNS; Nutriset, 
Malaunay, France) daily from 6 to 18 months; (3) 
processing locally available foods to facilitate masti-
cation and swallowing; (4) feeding during illness; (5) 
dietary diversity. Monthly delivery of SQ- LNS from 6 
to 18 months.
 ► WASH All SOC messages plus (1) safe disposal of 
faeces; (2) hand- washing with soap at key times; (3) 
protection of infants from geophagia and animal 
faeces ingestion; (4) chlorination of drinking water 
and (5) hygienic preparation of complementary food. 
Ventilated improved pit latrine constructed within 
6 weeks of enrolment; two hand- washing stations; 
plastic mat and play yard; monthly delivery of soap 
and chlorine (WaterGuard, Nelspot, Zimbabwe).
 ► IYCF+WASH All SOC, IYCF and WASH interventions.
A latrine was constructed in non- WASH arms following 
trial completion. Masking for participants and field-
workers was not possible, but investigators were blinded 
to trial arm.
 Maternal HIV testing
Local clinics undertook antenatal HIV testing and 
provided antiretroviral therapy (ART) to HIV- positive 
women. PMTCT guidelines in Zimbabwe changed from 
WHO Option B (combination ART for all HIV- positive 
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women during the pregnancy and breast feeding) to 
Option B+ (lifelong ART for pregnant and breastfeeding 
women) during the trial (from November 2013). In addi-
tion to local clinic services, we offered home HIV testing 
to mothers at baseline using an anti- HIV antibody rapid 
test algorithm (Alere Determine HIV-1/2 test, confirmed 
by INSTI HIV-1/2 test if positive); testing was repeated at 
32 gestational weeks to detect HIV seroconversion during 
pregnancy. Women testing HIV- positive had CD4 counts 
measured (Alere Pima, Abbott) and were referred to 
local clinics for ART. The trial did not measure HIV viral 
loads.
 Child HIV testing
HIV- positive women were encouraged to attend local 
clinics at 4–6 weeks post partum for early infant diag-
nosis, initiation of cotrimoxazole prophylaxis and, for 
HIV- infected children, ART initiation. Infants born to 
HIV- positive mothers were eligible for enrolment into a 
substudy in which biological specimens were collected 
longitudinally. For substudy infants, blood was tested 
for HIV (by PCR or rapid test, depending on age and 
sample) at 1, 3, 6, 12 and 18 months; infants not enrolled 
into the substudy were tested at 18 months. HEU children 
were defined as being born to HIV- positive mothers and 
testing HIV- negative at 18 months of age. HIV- exposed 
children, who were not tested at 18 months because of 
maternal refusal, missed visits or failure to obtain a spec-
imen or children who had inconclusive/discordant HIV 
results after retesting, were classified as HIV unknown. 
All HIV- positive children were referred to clinics for ART 
initiation.
 data collection
Research nurses made home visits at baseline (~2 weeks 
after consent), 32 weeks’ gestation and at 1, 3, 6, 12 and 
18 months postpartum to assess maternal and household 
characteristics and trial outcomes. Intervention uptake 
was assessed by participant behaviours at the 12- month 
postnatal visit.
eCd substudy
Infants who completed the trial and turned 2 years of age 
(allowable range 102–112 weeks) between 1 March 2016 
and 30 April 2017 were eligible to join the ECD substudy. 
Children were enrolled either during the 18- month trial 
endpoint visit, or following the 18 month SHINE visit but 
before the child turned 2 years of age.
 Assessment tools
A team of 11 research nurses completed 3 weeks of resi-
dential training in ECD assessment by the team psycholo-
gist (JC) and a neurodevelopmental paediatrician (MG). 
Several domains of ECD were assessed.
1. Malawi Developmental Assessment Tool (MDAT), 
measuring child development in four domains: gross 
and fine motor coordination, language and social. 
Fine motor, language and social domains also measure 
components of cognitive development.11 The MDAT 
was initially validated in Malawi (a very similar setting 
to Zimbabwe) and then piloted on 50 Zimbabwean 
children.
2. MacArthur Bates Communicative Development Inven-
tory (CDI), assessing language according to maternal 
report using vocabulary and grammar checklists.12 The 
test was specifically adapted for Shona speakers using a 
detailed protocol approved by the CDI team.13 14
3. A- not- B test, assessing object permanence and cogni-
tion.15
4. Self- control task, assessing impulsivity.16
 study outcomes
The ECD substudy design and outcomes were prespec-
ified in the study protocol and statistical analysis plan 
(https:// osf. io/ w93hy). The primary outcomes were 
MDAT total (out of 138), gross motor (out of 36), fine 
motor (out of 36), social (out of 30) and language (out 
of 36) scores; MacArthur Bates CDI vocabulary checklist 
(number of words known out of 99); A- not- B score (out 
of 10); and the proportion of children with self- control. 
The secondary outcomes were the proportion of children 
using the progressive tense, using plurals or combining 
two words (MacArthur Bates CDI grammar checklist).
Children with severe motor, visual, hearing or learning 
impairments as determined by the Washington Group 
questionnaire (child version)17 were excluded from anal-
yses and referred to local clinics.
 Validation and quality control
Every 6 months, nurses underwent refresher training 
and standardisation. Each nurse was observed while 
conducting an ECD assessment while a gold- standard 
assessor double- scored the assessment; percentage agree-
ment had to be >85% for certification, with retraining 
and retesting required for those who did not meet this 
threshold. In addition, all 11 nurses concurrently scored 
the same child: average interclass correlations across 
standardisations were: MDAT 0.88 (95% CI 0.82 to 0.94); 
MacArthur Bates 0.94 (95% CI 0.90 to 0.96); A- not- B 0.85 
(95% CI 0.80 to 0.90) and self- control task 0.80 (95% 
CI 0.76 to 0.85). Supportive supervision was undertaken 
during monthly field visits and nurses were provided with 
corrective or reinforcing feedback. A 5% subsample of 
assessments were video recorded, reviewed and double 
scored by a psychologist (JC) and a neurodevelopmental 
paediatrician with Shona language proficiency (GK). 
Percentage agreement for these video- taped assessments 
was 93% for MDAT fine motor, 90% for MDAT language, 
97% for A- not- B and 91% for the self- control task.
 statistical analysis
All analyses were intention to treat at the child level. The 
absolute difference in mean score between treatment 
groups was estimated for tests with continuous outcomes. 
For tests with dichotomous outcomes, the relative risk 
(RR) of passing was compared between treatment 
groups. Primary analyses used generalised estimating 
 o
n
 January 20, 2020 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2019-001718 on 13 January 2020. Downloaded from 
4 Chandna J, et al. BMJ Global Health 2020;5:e001718. doi:10.1136/bmjgh-2019-001718
BMJ Global Health
equations to account for within- cluster correlation, 
containing two dummy variables for the two interven-
tions, representing the main effect of the IYCF interven-
tion (the two IYCF- containing groups compared with the 
two groups without IYCF) and the WASH intervention 
(the two WASH- containing groups compared with the 
two groups without WASH), unadjusted for other covari-
ates, with an exchangeable working correlation structure. 
For each outcome, we estimated the statistical interac-
tion between the IYCF and WASH interventions. When 
the interaction was significant (p<0.05 according to the 
Wald test), results are based on a regression model with 
three dummy variables to represent IYCF, WASH and 
IYCF +WASH compared with SOC, instead of the model 
with two terms. Adjusted analyses controlled for prespec-
ified baseline covariates (mother’s mid- upper arm 
circumference, mother’s education, mother’s employ-
ment, maternal health perception, maternal capabili-
ties, improved latrine, low birth weight, prematurity, sex, 
calendar month, fieldworker, decimal age), which were 
initially assessed in bivariate analyses to identify those with 
an important association with the outcome (for dichoto-
mous outcomes: p<0.2 or RR >2.0 or <0.5; for continuous 
outcomes: p<0.2 or difference >0.25 SD). Selected covar-
iates were entered in a multivariable regression model; a 
forward stepwise selection procedure was implemented 
with p<0.2 to enter. A log- binomial specification was used 
to estimate RRs. Methods for comparing study arms while 
handling within- cluster correlation included multino-
mial and ordinal regression models with robust variance 
estimation, and Somers’ D for medians, were all imple-
mented in Stata V.14.
In a sensitivity analysis, HIV- positive and HIV- unknown 
children were excluded. A subgroup analysis by child 
gender was planned if there was a significant interaction 
between gender and study arms (as defined above).
 sample size
The sample size of the ECD substudy was based on 
detecting clinically relevant differences among HIV- 
unexposed children10; there was no specific sample size 
calculation for HIV- exposed children.
 Patient and public involvement
We did not directly include patient and public involve-
ment in this trial, but all community activities were 
discussed with traditional and elected leaders in both 
study districts, who provided advice through the District 
Health Executive, Social Services Committee and Rural 
District Council. A film of the SHINE trial is being made 
with community participation to capture the experience 
of being involved in a community- wide trial. The film will 
be screened in the two rural districts where SHINE was 
conducted.
 role of funder
Study funders approved the trial design, but were not 
involved in data collection, analysis or interpretation, 
nor decisions related to publication. The corresponding 
author had full access to all study data and ultimate 
responsibility for the decision to submit for publication.
 Trial oversight and registration
An independent data safety and monitoring board 
reviewed interim adverse event data.
resulTs
Among 5280 enrolled pregnant women, 726 tested HIV- 
positive during the pregnancy; of 738 infants born to 
these mothers, 475 were eligible for the ECD substudy, 
and 323 (68% of eligible) were enrolled from 142 clus-
ters (figure 1) during the period of enrolment (between 
1 March 2016 and 30 April 2017). Of the 152 children 
not enrolled, 94 (62%) had relocated temporarily or 
permanently from their study home; 41 (27%) were not 
reachable by telephone or home visit to determine avail-
ability and interest in joining the ECD substudy; 8 (5%) 
declined; 4 (3%) could not be scheduled at a mutually 
agreeable time within the required age window; and 3 
(2%) died between 18 and 24 months of age.
 baseline characteristics
At baseline, approximately half of all household members 
practised open defecation, and just over one- third had a 
household latrine (table 1). About 40% of households 
consumed a minimally diverse diet. Among mothers, 
mean (SD) CD4 count was 461 (218) cells/µL; 88% 
and 67% received ART and cotrimoxazole, respectively, 
during the pregnancy. There were some minor baseline 
imbalances in improved latrine ownership, observed 
chicken faeces in households, wealth index, mode of 
delivery and birth weight between arms. HIV- positive 
mothers who enrolled in the ECD substudy were about 
3 years older than those who did not enrol, SOC and 
IYCF +WASH enrolled mothers had higher institutional 
delivery (92% vs 74%) while IYCF and WASH arms were 
similar; other baseline characteristics of mother–infant 
dyads who enrolled or did not enrol were similar (online 
supplementary table 1).
 delivery and uptake of interventions
Across randomised arms, the fidelity of providing inter-
vention supplies (WASH hardware, liquid soap, chlorine 
and SQ- LNS) was high, and >90% of expected behavioural 
change modules were delivered by VHWs (table 2). Open 
defecation was virtually eliminated in the WASH arms: 
<1% households reported practising open defecation 
compared with half in non- WASH arms. Among WASH 
compared with non- WASH households, fewer mothers 
reported ever seeing their child ingest soil and chicken 
faeces. Over 90% of children in all treatment arms were 
still breast feeding at 12 months. A higher proportion of 
infants in the IYCF arms had consumed a diet that met 
minimum dietary diversity and had consumed animal- 
source, iron- rich and vitamin A- rich foods in the previous 
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Figure 1 Flow of participants through the trial. 1A total of 212 clusters were randomised, 53 in each of the four trial arms. 
After randomisation, one cluster was excluded as it was determined to be in an urban area, one cluster was excluded as the 
VHW covering it mainly had clients outside the study area, and one more was merged into a neighbouring cluster based on 
subsequent data on VHW coverage. Three new cluster designations were created due to anomalies in the original mapping: 
for two of these, the trial arm was clear; the third contained areas that were in two trial arms and was assigned to the 
underrepresented arm, resulting in 53 clusters in each arm. All of this occurred before enrolment began. When enrolment was 
completed, however, there was one cluster (SOC) in which no women were enrolled, leaving a total of 211 clusters available 
for analysis. 2IYCF, infant and young child feeding; SOC, standard- of- care; WASH, water, sanitation and hygiene. 3Children 
were not eligible for the early child development (ECD) substudy if they turned 2 years of age (allowable range 102–112 weeks) 
before 1 March 2016. 4Children were eligible for the ECD substudy if they turned 2 years of age (allowable range 102–112 
weeks) between 1 March 2016 and 30 April 2017. 5A total of 152 children were eligible but not enrolled: 94 (62%) had relocated 
temporarily or permanently from their study home; 41 (27%) were not reachable by telephone or home visit to determine 
availability and interest in joining the ECD substudy; 8 (5%) declined; 4 (3%) could not be scheduled at a mutually agreeable 
time within the required age window; and 3 (2%) died between 18 and 24 months of age. VHW, village health worker.
day. Almost all children in the IYCF arms had consumed 
SQ- LNS in the previous 24 hours.
 effect of randomised intervention on eCd outcomes
The age at the ECD assessment visit was very similar 
across trial arms (SOC: mean (SD) 105.4 (2.2) weeks; 
IYCF: 105.0 (2.0) weeks; WASH: 105.1 (1.9) weeks and 
IYCF+WASH 105.6 (2.1) weeks). Of the 323 enrolled 
children, two (1%) were excluded due to severe disa-
bility, and three (1%) were excluded because they were 
subsequently found to be outside the predefined age 
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Table 1 Maternal, household and infant baseline characteristics of HIV- positive mothers and their liveborn infants in the early 
child development substudy
Baseline characteristics*
Standard- of- 
care IYCF WASH LYCF+WASH
  Mothers 68 67 81 102
  Infants 68 68 83 104
  Mothers completing baseline visit 67 65 80 101
  Household characteristics
  Median no of occupants (IQR) 5 (3–6) 4 (3–6) 5 (3–6) 4 (3–6)
Wealth quintile:†
  1 (lowest) 16/68 (23.5%) 14/67 (20.9%) 20/81 (24.7%) 28/102 (27.5%)
  2 16/68 (23.5%) 13/67 (19.4%) 15/81 (18.5%) 19/102 (18.6%)
  3 12/68 (17.7%) 13/67 (19.4%) 19/81 (23.5%) 17/102 (16.7%)
  4 8/68 (11.8%) 17/67 (25.4%) 11/81 (13.6%) 17/102 (16.7%)
  5 (highest) 14/68 (20.6%) 8/67 (11.9%) 13/81 (16.1%) 19/102 (18.6%)
Electricity
  Connected to power grid 3/66 (4.6%) 3/65 (4.6%) 0/78 (0.0%) 3/100 (4.0%)
Other power source
  Use a generator 2/66 (3.0%) 3/65 (4.6%) 0/78 (0.0%) 3/100 (3.0%)
  Use solar power 45/66 (68.2%) 44/65 (67.7%) 56/78 (71.8%) 64/100 (64.0%)
  No electricity 19/66 (28.8%) 18/65 (27.7%) 22/78 (28.2%) 33/100 (33.0%)
Sanitation
  Household members defecate in the open 177/302 (58.6%) 151/282 (53.6%) 182/337 (54.0%) 196/426 (46.0%)
  Any latrine at household 18/66 (27.3%) 28/62 (45.2%) 29/77 (37.7%) 37/96 (38.5%)
  Improved latrine at household 17/66 (25.8%) 24/62 (38.7%) 25/77 (32.5%) 36/96 (37.5%)
  Improved latrine with well- trodden path and not 
shared with other households and not used for 
storage
12/64 (18.8%) 28/60 (31.7%) 29/76 (27.6%) 23/94 (24.5%)
Water
  Main source of household drinking water is 
improved
41/66 (62.1%) 36/62 (58.1%) 44/77 (57.1%) 59/96 (61.5%)
  Treat drinking water to make it safer 13/64 (20.3%) 11/62 (17.7%) 10/77 (13.0%) 13/96 (13.5%)
  Median one- way walk time to fetch water (IQR); 
min
10 (5–20) 9 (3–15) 10 (5–15) 9 (5–20)
  Mean water volume collected per person in past 
24 hours (SD); L
8.7 (4.6) 9.4 (6.7) 9.1 (6.7) 10.3 (8.2)
Hygiene
  Hand- washing station at household 3/54 (5.6%) 4/62 (6.5%) 11/74 (14.9%) 15/91 (16.5%)
  Hand- washing station with water and rubbing 
agent
0/54 (0.0%) 0/60 (0.0%) 0/74 (0.0%) 1/91 (1.1%)
  Improved floor‡ 31/65 (47.7%) 35/65 (53.9%) 35/77 (45.5%) 48/98 (49.0%)
  Median no of chickens (IQR) 4 (1–8) 6 (2–10.5) 5 (3–8) 4 (1–8)
  Livestock observed inside home 28/66 (42.4%) 19/67 (28.4%) 34/79 (43.0%) 33/99 (33.3%)
  Faeces observed in yard 25/65 (38.5%) 18/66 (27.3%) 27/78 (34.6%) 17/98 (17.4%)
Diet quality and food security
  Household meets minimum dietary diversity§ 21/55 (38.2%) 22/57 (38.6%) 24/74 (32.9%) 37/83 (44.6%)
  Median Coping Strategies Index score¶ (IQR) 4 (0–9.5) 2 (0–15) 3 (0–11) 1 (0–9)
Maternal characteristics
  Mean age (SD), years 30.8 (5.7) 30.9 (7.2) 30.4 (5.7) 30.9 (5.8)
Continued
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Baseline characteristics*
Standard- of- 
care IYCF WASH LYCF+WASH
  Mean height (SD), cm 161.3 (7.8) 160.3 (6.4) 160.5 (5.3) 159 (6.6)
  Mean mid- upper arm circumference (SD), cm 26.8 (3.4) 26.3 (3.6) 26.4 (2.2) 26.5 (2.8)
  Positive microscopy for Schistosoma 
haematobium
6/67 (9.0%) 4/65 (6.2%) 12/78 (15.4%) 9/101 (8.9%)
  Mean years of completed schooling (SD) 9.5 (1.8) 9.1 (2.1) 8.7 (2.2) 9.3 (2.1)
  Median parity (IQR) 3 (1–3) 2 (1–3) 3 (2–4) 2 (1–3)
  Married 61/64 (95.3%) 59/63 (93.7%) 71/73 (97.3%) 85/92 (92.4%)
  Employed 5/65 (7.7%) 5/65 (7.7%) 8/78 (10.3%) 8/100 (8.0%)
Religion
  Apostolic 34/63 (54.0%) 32/63 (50.8%) 34/74 (46.0%) 46/93 (49.5%)
  Other christian religions 25/63 (39.7%) 25/63 (39.7%) 30/74 (40.5%) 41/93 (44.1%)
  Other 4/63 (6.4%) 6/63 (9.5%) 10/74 (13.5%) 6/93 (6.5%)
HIV disease severity and treatment
  Mean CD4 count in pregnancy (SD)**, cells/µL 474 (180) 478 (186) 421 (187) 470 (217)
  Antiretroviral therapy during pregnancy†† 60/68 (88.2%) 60/67 (89.6%) 65/81 (80.3%) 90/102 (88.2%)
  Cotrimoxazole prophylaxis during pregnancy‡‡ 40/68 (58.8%) 42/67 (62.7%) 55/81 (67.9%) 63/102 (61.8%)
Infant characteristics
  Female 33/68 (48.5%) 32/63 (47.1%) 39/83 (47.0%) 55/104 (52.9%)
  Mean birth weight (SD), kg 3.03 (0.45) 2.94 (0.49) 3.07 (0.66) 3.02 (0.50)
  Low birth weight <2500 g 8/68 (11.8%) 10/68 (14.7%) 6/83 (7.2%) 11/104 (10.6%)
  Institutional delivery 59/64 (92.2%) 55/66 (83.3%) 67/79 (84.8%) 85/92 (92.4%)
  Vaginal delivery 62/66 (93.9%) 57/62 (87.7%) 76/80 (95.0%) 90/98 (91.8%)
*Baseline variables presented for mothers who had live births; maternal and household data were collected about 2 weeks after consent (~14 
weeks gestation); this gap created opportunity for lost to follow- up between consent and baseline, thus the number of mothers completing 
the baseline visit is fewer than the number of mothers with live births. Baseline for infants was at birth. Values are %, unless noted. For 
variables where (n) is not stated, <3% of data are missing based on number of baseline visits completed.
†Chasekwa et al.23
‡Improved floor defined as concrete, brick, cement or tile. Unimproved floor defined as mud, earth, sand or dung.
§FAO, FHI 360. Minimum Dietary Diversity for Women: A Guide for Measurement. Rome: FAO. 2016.
¶Maxwell et al.24
**CD4 count at baseline visit, or at 32 gestational week visit if no baseline result.
††Includes any exposure to antiretroviral therapy during pregnancy; only documented for 86% of participants.
‡‡Includes any exposure to co- trimoxazole during pregnancy; only documented for 81% of participants.
.IYCF, infant and young child feeding; WASH, water, sanitation and hygiene.
Table 1 Continued
window (102–112 weeks). Two children (both in the 
IYCF+WASH arm) were assessed after the substudy enrol-
ment period ended, but were otherwise eligible and 
were included. The final analysis therefore included 318 
HIV- exposed children (figure 1), of whom 6 were HIV- 
positive, 300 HEU and 12 HIV- unknown.
There was a significant interaction between the WASH 
and IYCF interventions for the total MDAT score and 
MacArthur Bates CDI vocabulary checklist; therefore, 
scores for these tests were analysed and presented sepa-
rately for the four treatment arms. There was no inter-
action between the randomised interventions for the 
object permanence and self- control tests; therefore, the 
main effects of IYCF and WASH are presented for these 
tests.
 MdAT scores
At 24 months, the total MDAT score was higher among 
children in the IYCF +WASH group compared with the 
SOC group (unadjusted difference +4.6; 95% CI 1.9 to 
7.2). This difference corresponds to a 0.50 SD increase in 
total MDAT score, and was driven by higher scores in all 
components of the MDAT test (table 3). In adjusted anal-
yses, the total MDAT score remained significantly higher in 
the IYCF +WASH group (adjusted difference +3.1; 95% CI 
0.9 to 5.3); differences in individual components of the 
MDAT score were attenuated and no longer reached statis-
tical significance for the fine motor and language compo-
nent scores. There was no evidence of effect from the IYCF 
or WASH interventions alone, either on total MDAT score 
or any of the MDAT component scores.
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 MacArthur bates CdI vocabulary and grammar checklists
Compared with SOC, children in the IYCF +WASH arm 
had higher MacArthur Bates CDI vocabulary scores (+8.5 
words; 95% CI 3.7 to 13.3), corresponding to an increase 
of 0.44 SD. Twice as many children in the IYCF +WASH arm 
reportedly used plurals (RR 2.08; 95% CI 0.98 to 4.41), 
although this difference was no longer significant in the 
adjusted analysis. There was no evidence of an effect of 
IYCF +WASH on the proportion of children combining 
two words or using the progressive tense. There was no 
evidence that either the IYCF or WASH interventions, 
when implemented alone, impacted any component of 
the MacArthur Bates CDI score (table 3).
 object permanence and self-control
There was no interaction between interventions for 
either test, so the IYCF arms were compared with non- 
IYCF arms, and the WASH arms were compared with 
non- WASH arms. There was no evidence of differences 
between intervention groups in object permanence or 
in the proportion of children with self- control (table 3). 
Inferences were similar in adjusted analyses.
 sensitivity and subgroup analyses
When effects of the interventions were restricted to 
children confirmed as HEU (ie, removing children 
who were HIV- positive and HIV- unknown at 18 months 
of age), overall findings were similar (table 4). There 
was a significant interaction between child gender and 
randomised interventions for the total MDAT score. 
Results stratified by gender showed that among girls, 
those in the combined IYCF+WASH arm had significantly 
higher motor, language and social scores than those 
in the SOC arm. Among boys, those in the combined 
IYCF+WASH arm had significantly higher language and 
social scores than those in the SOC arm, but there was 
no evidence of an intervention effect on motor scores 
(online supplementary table 2).
dIsCussIon
In this analysis of children born to HIV- positive mothers 
in rural Zimbabwe, a package combining IYCF and WASH 
interventions significantly improved motor, language 
and cognitive development at 2 years of age compared 
with those receiving enhanced SOC. The same IYCF and 
WASH interventions when delivered individually (rather 
than as a combined package) had no impact on ECD at 
2 years of age. These findings are contrary to previously 
reported findings from the SHINE trial among a larger 
group of 3686 HIV- unexposed children, in whom the 
IYCF and WASH interventions, delivered either alone or 
together, had no meaningful impact on ECD. We suggest 
from these collective findings that HIV exposure in early 
life is a distinct challenge and that HEU children may be 
particularly responsive to a package of interventions to 
improve neurocognitive development.
The SHINE trial was designed to evaluate the effects 
of IYCF and WASH on linear growth and haemoglobin, 
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Table 3 Effect of WASH and IYCF interventions on early child development at 24 months among HIV- exposed children
Primary 
continuous 
outcomes
Effects by each randomised arm compared with the SOC ARM
Treatment 
group N Mean (SD)
Unadjusted 
difference
(95% CI) P value
Adjusted difference*
(95% CI) P value
MDAT total 
score
SOC 66 90.9 (8.2) 0.0 (ref) 0.0 (ref)
IYCF 66 91.7 (8.8) 0.81 (−1.99 to 3.61) 0.572 −0.91 (−3.40 to 1.58) 0.476
WASH 83 89.6 (9.2) −1.26 (−3.80 to 1.28) 0.330 −1.63 (−4.26 to 0.99) 0.222
IYCF+WASH 103 95.3 (9.0) 4.57 (1.91 to 7.23) 0.001 3.05 (0.86 to 5.25) 0.006
MDAT gross 
motor
SOC 66 23.1 (2.8) 0.0 (ref) 0.0 (ref)
IYCF 66 23.4 (2.7) 0.38 (−0.50 to 1.27) 0.398 0.01 (−0.88 to 0.91) 0.977
WASH 83 22.7 (3.2) −0.25 (−1.00 to 0.49) 0.504 −0.57 (−1.39 to 0.25) 0.174
IYCF+WASH 103 24.3 (3.3) 1.50 (0.53 to 2.47) 0.002 0.84 (0.08 to 1.61) 0.031
MDAT fine 
motor
SOC 66 23.0 (2.4) 0.0 (ref) 0.0 (ref)
IYCF 66 22.7 (3.5) −0.31 (−1.37 to 0.74) 0.558 −0.50 (−1.52 to 0.51) 0.329
WASH 83 22.9 (2.6) −0.10 (−0.86 to 0.66) 0.804 −0.21 (−1.11 to 0.68) 0.637
IYCF+WASH 103 23.8 (2.6) 0.74 (−0.02 to 1.50) 0.055 0.59 (−0.21 to 1.38) 0.148
MDAT 
language
SOC 66 20.7 (3.7) 0.0 (ref) 0.0 (ref)
IYCF 66 20.9 (4.2) 0.21 (−1.13 to 1.55) 0.756 −0.65 (−1.76 to 0.46) 0.250
WASH 83 20.0 (3.9) −0.73 (−1.87 to 0.41) 0.209 −1.09 (−2.24 to 0.06) 0.062
IYCF+WASH 103 22.2 (4.1) 1.48 (0.20 to 2.77) 0.024 0.65 (−0.33 to 1.63) 0.196
MDAT social SOC 66 24.1 (2.1) 0.0 (ref) 0.0 (ref)
IYCF 66 24.7 (2.2) 0.53 (−0.00 to 1.06) 0.052 0.19 (−0.37 to 0.75) 0.510
WASH 83 24.0 (2.4) −0.08 (−0.70 to 0.55) 0.811 −0.23 (−0.80 to 0.34) 0.431
IYCF+WASH 103 25.0 (2.2) 0.99 (0.49 to 1.48) <0.001 0.61 (0.13 to 1.09) 0.013
McArthur 
Bates (CDI)
SOC 66 56.6 (18.5) 0.0 (ref) 0.0 (ref)
IYCF 65 57.6 (21.3) 1.00 (−5.74 to 7.55) 0.771 −2.47 (−8.60 to 3.67) 0.431
WASH 79 58.2 (20.1) 1.58 (−4.12 to 7.29) 0.586 −2.27 (−8.14 to 3.60) 0.448
IYCF+WASH 99 65.1 (17.0) 8.50 (3.66 to 13.33) 0.001 6.01 (1.14 to 10.88) 0.015
Effects comparing WASH versus non- WASH and IYCF versus non- IYCF
Treatment 
group
N Mean (SD) Treatment group N Mean (SD) Unadjusted 
difference (95% CI)
P 
value
Adjusted* 
difference (95% CI)
P 
value
A not B SOC 55 7.9 (1.3) IYCF: no 131 7.8 (1.4) 0.0 (ref) 0.0 (ref)
IYCF 62 7.7 (1.3) IYCF: yes 156 7.7 (1.3) −0.11 (−0.42 to 0.20) 0.487 0.05 (−0.24 to 0.34) 0.745
WASH 76 7.8 (1.5) WASH: no 117 7.8 (1.3) 0.0 (ref) 0.0 (ref)
IYCF+WASH 94 7.7 (1.3) WASH: yes 170 7.8 (1.4) 0.0 (−0.30 to 0.31) 0.994 −0.10 (−0.38 to 0.18) 0.472
Primary 
dichotomous 
outcomes
Treatment 
group
N n (%) Treatment group N n (%) Unadjusted relative 
risk (95% CI)
P 
value
Adjusted relative 
risk (95% CI)
P 
value
Self- control 
task (hidden)
SOC 62 17 (27.4%) IYCF: no 144 49 (34.0%) 1.00 (ref) 1.00 (ref)
IYCF 66 25 (37.9%) IYCF: yes 168 58 (34.5%) 1.00 (0.74 to 1.34) 0.975 1.05 (0.77 to 1.45) 0.743
WASH 82 32 (39.0%) WASH: no 128 42 (32.8%) 1.00 (ref) 1.00 (ref)
IYCF+WASH 102 33 (32.4%) WASH: yes 184 65 (35.3%) 1.08 (0.78 to 1.49) 0.631 0.97 (0.69 to 1.37) 0.878
Self- control 
task 
(unhidden)
SOC 61 30 (49.2%) IYCF: no 142 79 (55.6%) 1.00 (ref) 1.00 (ref)
IYCF 66 35 (53.0%) IYCF: yes 166 88 (53.0%) 0.94 (0.77 to 1.41) 0.522 0.92 (0.73 to 1.15) 0.458
WASH 81 49 (60.5%) WASH: no 127 65 (51.2%) 1.00 (ref) 1.00 (ref)
IYCF+WASH 100 53 (53.0%) WASH: yes 181 102 (56.4%) 1.11 (0.90 to 1.36) 0.350 1.09 (0.86 to 1.38) 0.467
Secondary 
dichotomous 
language 
outcomes
Effects by each randomised arm compared with the SOC ARM
Treatment 
group
N N (%) Unadjusted relative 
risk
(95% CI)
P Adjusted relative risk
(95% CI)
P
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Primary 
continuous 
outcomes
Effects by each randomised arm compared with the SOC ARM
Treatment 
group N Mean (SD)
Unadjusted 
difference
(95% CI) P value
Adjusted difference*
(95% CI) P value
Uses plurals SOC 66 8 (12.1%) 1.00 (ref) 1.00 (ref)
IYCF 66 17 (25.8%) 1.97 (0.91 to 4.27) 0.087   1.05 (0.49 to 2.22) 0.906
WASH 83 14 (16.7%) 1.21 (0.51 to 2.88) 0.667   1.15 (0.58 to 2.26) 0.695
IYCF+WASH 103 27 (26.2%) 2.08 (0.98 to 4.41) 0.055   1.57 (0.79 to 3.11) 0.195
Combines 
two words
SOC 66 64 (97.0%) 1.00 (ref) 1.00 (ref)
IYCF 66 63 (95.5%) 0.99 (0.92 to 1.06) 0.737   0.99 (0.92 to 1.05) 0.646
WASH 83 82 (98.8%) 1.02 (0.97 to 1.07) 0.407   1.01 (0.96 to 1.07) 0.722
IYCF+WASH 103 103 (100.0%) 1.03 (0.99 to 1.08) 0.158   1.01 (0.97 to 1.06) 0.566
Uses 
imperatives
SOC 66 49 (74.2%) 1.00 (ref) 1.00 (ref)
IYCF 66 46 (69.7%) 0.94 (0.78 to 1.13) 0.479   0.92 (0.75 to 1.11) 0.380
WASH 83 57 (68.7%) 0.91 (0.81 to 1.02) 0.123   0.86 (0.71 to 1.05) 0.139
IYCF+WASH 102 77 (75.5%) 1.00 (0.87 to 1.15) 0.973   1.01 (0.84 to 1.21) 0.940
*Scores were adjusted for the following variables: maternal baseline mid- upper arm circumference, education, employment status, CD4 count, cotrimoxazole prophylaxis and 
antiretroviral treatment during pregnancy, capabilities (perceived physical health and decision- making autonomy), access to improved latrine; infant low birth weight, prematurity, 
gender and age at assessment; season of recruitment and research nurse who carried out the assessment.
CDI, Communication Development Inventory; IYCF, infant and young child feeding; MDAT, Malawi Developmental Assessment Tool; SOC, standard- of- care; WASH, water, sanitation 
and hygiene.
Table 3 Continued
which are both associated with child development. In 
the SHINE trial, among children born to HIV- negative 
mothers, the IYCF intervention increased LAZ by 0.16 
(95% CI 0.08 to 0.23) and haemoglobin by 2.03 (95% CI 
1.28 to 2.79) g/L at 18 months of age, while the WASH 
intervention had no effect on these outcomes.8 Among 
668 children born to HIV- positive mothers, the effects of 
the IYCF intervention exceeded those seen in the HIV- 
unexposed group, increasing mean Length for Age Z 
score (LAZ) by 0.26 (95% CI 0.09 to 0.43) and haemo-
globin by 2.9 (95% CI 0.9 to 4.9) g/L, while the WASH 
intervention had no effect on these outcomes.9 In both 
analyses, implementing WASH together with IYCF had 
no additional impact on stunting or anaemia compared 
with delivering IYCF alone. In the current analysis, HIV- 
exposed children randomised to a package of combined 
IYCF +WASH interventions had significantly improved 
motor, social and language development compared with 
HIV- exposed children receiving SOC interventions; by 
contrast, those randomised to receive either the IYCF 
or WASH intervention alone had similar ECD scores to 
control children. It is difficult to explain why combining 
IYCF and WASH improved neurodevelopment in HIV- 
exposed children when we found little evidence of 
benefit from either intervention delivered alone. We did 
not see this level of synergy between the interventions 
in HIV- unexposed children, although the study was not 
powered to distinguish between interactions in these two 
subgroups. However, among the HIV- exposed children, 
we found consistent, statistically significant improve-
ments across multiple tests of global child development. 
These included specific motor, social and language 
scores, which exhibited substantial magnitudes of effect 
between IYCF +WASH and SOC of 0.4–0.5 SD.18 19 These 
effect sizes effects are considerable for child develop-
ment at this age.
We have previously reported that HEU children had 
evidence of modestly reduced developmental scores 
compared with HIV- unexposed children in SHINE,20 
but we suggest from the results of this current study 
that they may also be more responsive to interventions 
(online supplementary table 3). The IYCF intervention 
was designed to improve nutrient intake during a crit-
ical period of growth and brain development, while the 
WASH intervention was designed to reduce exposure 
to pathogens and to prevent a subclinical inflammatory 
disorder of the gut termed EED. Perhaps ECD improve-
ments in these vulnerable children are only realised when 
gut health and nutrient requirements are both addressed 
simultaneously. A healthier intestinal milieu may facili-
tate absorption and prevent wastage of nutrients from 
the IYCF intervention, or modulate the microbiota–
gut–brain axis to improve neurodevelopment. Further 
planned laboratory studies of EED biomarkers, pathogen 
carriage and growth hormone activity will help to address 
the underlying pathways. We anticipated that the infant 
feeding intervention alone would lead to improvements 
in ECD, since IYCF reduced stunting at 18 months of age, 
but IYCF alone had no evidence of benefit for neuro-
development. There was no evidence for a synergistic 
effect of IYCF and WASH on linear growth at 18 months 
of age, although children randomised to this group did 
have a larger head circumference (mean Z- score −0.38, 
compared with SOC −0.55, IYCF −0.51 and WASH −0.53). 
It is, therefore, plausible that HIV- exposed children 
prioritise head growth over linear growth; however, this 
difference was already apparent from as early as 1 month 
of age. We are, therefore, uncertain whether our findings 
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Table 4 Effect of WASH and IYCF interventions on early child development at 24 months among HIV- exposed uninfected 
children
Primary continuous 
outcomes
Effects by each randomised arm compared with the SOC ARM
Treatment group N Mean (SD)
Unadjusted difference 
between means (95% CI) P value
MDAT total score SOC 63 90.7 (8.1) 0.0 (ref)
IYCF 63 91.8 (8.6) 1.26 (–1.40 to 3.91) 0.353
WASH 79 89.6 (9.2) −0.81 (–3.30 to 1.68) 0.525
IYCF+WASH 95 95.5 (9.0) 5.70 (3.00 to 8.39) <0.001
MDAT gross motor SOC 63 23.0 (2.6) 0.0 (ref)
IYCF 63 23.5 (2.8) 0.51 (–0.40 to 1.41) 0.271
WASH 79 22.7 (3.3) −0.27 (–1.06 to 0.52) 0.500
IYCF+WASH 95 24.2 (3.3) 1.21 (0.37 to 2.06) 0.005
MDAT fine motor SOC 63 22.9 (2.4) 0.0 (ref)
IYCF 63 22.7 (3.5) −0.24 (–1.33 to 0.85) 0.662
WASH 79 22.9 (2.7) −0.03 (–0.80 to 0.75) 0.946
IYCF+WASH 95 23.8 (2.6) 0.88 (0.11 to 1.65) 0.024
MDAT language SOC 63 20.7 (3.8) 0.0 (ref)
IYCF 63 21.0 (4.1) 0.29 (–1.03 to 1.61) 0.669
WASH 79 20.1 (3.9) −0.64 (–1.80 to 0.53) 0.284
IYCF+WASH 95 22.4 (4.0) 1.78 (0.45 to 3.11) 0.009
MDAT social SOC 63 24.1 (2.1) 0.0 (ref)
IYCF 63 24.7 (2.2) 0.55 (0.00 to 1.09) 0.050
WASH 79 24.0 (2.4) −0.04 (–0.65 to 0.57) 0.896
IYCF+WASH 95 25.1 (2.2) 1.08 (0.56 to 1.60) <0.001
  MacArthur Bates 
(CDI)
SOC 63 56.9 (18.3) 0.0 (ref)
IYCF 62 58.4 (20.7) 1.70 (–4.84 to 8.24) 0.610
WASH 75 58.4 (18.9) 1.65 (–3.57 to 6.87) 0.535
IYCF+WASH 91 66.0 (15.9) 9.36 (4.62 to 14.10) <0.001
  Effects comparing WASH versus non- WASH and IYCF versus non- IYCF
Treatment group N Mean (SD) Treatment 
group
N Mean (SD) Unadjusted 
difference between 
means (95% CI)
P value
A not B SOC 52 7.8 (1.3) IYCF: no 124 7.8 (1.4) 0.0 (ref)
IYCF 59 7.6 (1.3) IYCF: yes 145 7.7 (1.3) −0.11 (–0.43 to 0.22) 0.529
WASH 72 7.8 (1.5) WASH: no 111 7.7 (1.3) 0.0 (ref)
IYCF+WASH 86 7.7 (1.3) WASH: yes 158 7.8 (1.4) 0.03 (–0.30 to 0.35) 0.878
Primary 
dichotomous 
outcomes
Treatment group N n (%) Treatment 
group
N n (%) Unadjusted relative 
risk (95% CI)
P value
Self- control task 
(hidden)
SOC 59 16 (27.1%) IYCF: no 137 47 (34.3%) 1.00 (ref)
IYCF 63 24 (38.1%) IYCF: yes 157 53 (33.8%) 1.07 (0.77 to 1.49) 0.698
WASH 78 31 (39.7%) WASH: no 122 40 (32.8%) 1.00 (ref)
IYCF+WASH 94 29 (30.9%) WASH: yes 172 60 (34.9%) 0.97 (0.71 to 1.32) 0.839
Self- control task 
(unhidden)
SOC 58 27 (46.6%) IYCF: no 135 74 (54.8%) 1.00 (ref)
IYCF 63 34 (54.0%) IYCF: yes 155 83 (53.5%) 0.94 (0.77 to 1.15) 0.563
WASH 77 47 (61.0%) WASH: no 121 61 (50.4%) 1.00 (ref)
IYCF+WASH 92 49 (53.3%) WASH: yes 169 96 (56.8%) 1.14 (0.92 to 1.41) 0.219
Secondary 
dichotomous 
language 
outcomes
Effects by each randomised arm compared with the SOC ARM
Treatment group N n (%) Unadjusted Relative Risk 
(95% CI)
P value
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Primary continuous 
outcomes
Effects by each randomised arm compared with the SOC ARM
Treatment group N Mean (SD)
Unadjusted difference 
between means (95% CI) P value
Uses plurals SOC 63 8 (12.7%) 1.00 (ref)   
IYCF 63 16 (25.4%) 1.87 (0.85 to 4.12) 0.118
WASH 79 13 (16.5%) 1.14 (0.48 to 2.68) 0.764
IYCF+WASH 95 27 (28.4%) 2.18 (1.03 to 4.60) 0.041
Combines two 
words
SOC 63 61 (96.8%) 1.00 (ref)   
IYCF 63 61 (96.8%) 1.00 (0.94 to 1.06) 0.990
WASH 79 78 (98.7%) 1.02 (0.97 to 1.07) 0.446
IYCF+WASH 95 95 (100%) * –
Uses imperatives SOC 63 47 (74.6%) 1.00 (ref)   
IYCF 63 45 (71.4%) 0.96 (0.80 to 1.15) 0.645
WASH 79 55 (69.6%) 0.93 (0.80 to 1.09) 0.387
IYCF+WASH 95 71 (75.5%) 1.01 (0.87 to 1.17) 0.869
*All the children in the IYCF+WASH arm combined two words.
CDI, Communicative Development Inventory; IYCF, infant and young child feeding; MDAT, Malawi Developmental Assessment Tool;SOC, standard- 
of- care; WASH, water, sanitation and hygiene.
Table 4 Continued
reflect a true effect of the combined intervention on 
ECD, and we also need to consider alternative explana-
tions for these results.
First, it is possible that there was residual confounding in 
this substudy. Although our findings remained consistent 
after adjusting for known confounders, there may have 
been imbalances in unmeasured factors at baseline. This 
study was nested within a larger randomised controlled 
trial, where children were identified and offered enrol-
ment during the period of this substudy if they met strict 
age criteria. There were some differences in rates of 
enrolment into the ECD study across the treatment arms 
which may have created bias. There was balance on base-
line demographics across trial arms for those who were 
enrolled in the substudy, which increases our confidence 
in the internal validity of our findings. Overall, there 
was similarity between those who were enrolled and not 
enrolled from the main SHINE trial; however, there were 
some differences that may influence external validity, 
such as a higher rate of institutional delivery and a shorter 
walk- time to water in the IYCF+WASH arm among those 
assessed for ECD compared with those not assessed.
Given our incomplete understanding of the inter-
linking pathways between HIV exposure and neurodevel-
opment, it is unlikely that all factors were accounted for 
in our analyses. For example, it is possible that children 
in the IYCF- only group had more risk factors (constraints 
at the maternal, child and household level) for poor ECD 
which we have not been able to evaluate compared with 
other groups so that the benefits of the IYCF intervention 
were only observed in the combined IYCF +WASH group. 
These risk factors may be related to the caregiver’s capacity 
to provide responsive caregiving, in turn, affecting the 
child’s development. Second, the households in the 
combined IYCF +WASH group received more trial inputs 
than the IYCF- only or WASH- only groups. In designing 
SHINE, we were careful to ensure that all families received 
the same number of VHW contacts; however, visits in the 
IYCF +WASH arm were longer and households in the 
combined IYCF +WASH group received more hardware 
(latrine and tippy taps) and commodities (chlorine, soap 
and SQ- LNS) than the IYCF- only or WASH- only groups. 
Both the IYCF and WASH modules may have increased 
the interactions between mother and child (eg, washing 
child’s hands and providing responsive feeding) and 
given the strong evidence linking positive maternal–child 
interaction and ECD outcomes, it is possible that these 
combined interventions in some way enabled an increase 
in interaction time to impact ECD scores. In addition, 
the positive impact of receiving inputs which included 
longer visits as well as the material goods (a latrine, 
tippy tap and nutritional supplements) may have posi-
tively impacted maternal mental health and well- being 
which may have influenced ECD outcomes.21 22 Quality 
of caregiving and responsivity plays a critical role within 
ECD intervention studies and it may be that the addi-
tional inputs and VHW time that were provided in the 
combined group with both curricula improved maternal 
well- being and enabled increased responsivity more in 
the vulnerable HIV- positive women than in HIV- negative 
women, and this, in turn, improved ECD in their chil-
dren. In other words, the ‘double’ training pack received 
from VHWs along with the additional inputs may have 
enabled mothers to be more responsive to the health and 
developmental needs of their HEU children. This may 
also reflect the fact that we saw a specific neurodevelop-
mental profile change in the areas of language and fine 
motor development (both closely linked to responsive 
caregiving) than in the gross motor and social compo-
nents of development. With this in mind, a package of 
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interventions which enhances quality caregiving and 
responsivity as much as possible may be what is needed to 
meaningfully impact ECD.
We found a significant interaction between child gender 
and trial intervention. Among girls, compared with the 
SOC arm, those in the combined IYCF+WASH arm had 
significantly higher motor, language and social scores. 
Among boys, compared with the SOC arm, those in the 
combined IYCF+WASH arm had significantly higher 
language and social scores, but there was no evidence of 
an effect on motor scores. Among children in the SOC 
arm, boys generally had poorer language and social scores 
than girls, whereas motor scores were similar; it is possible 
that whereas girls generally responded to IYCF+WASH 
interventions in all domains, boys only responded when 
developmental delays were more pronounced.
This analysis has several strengths. To our knowledge, 
this is the first intervention trial evaluating ECD outcomes 
in HIV- exposed children, who are an expanding popu-
lation in regions with high ongoing antenatal HIV 
prevalence. By using several different developmental 
assessment tools, we were able to thoroughly assess 
ECD across a broad range of domains. We adapted our 
assessment tools for use in rural Zimbabwe, and under-
took extensive piloting, quality control and standardi-
sation. We were able to report the findings specifically 
for HEU children, who now comprise the vast majority 
of children born to HIV- infected mothers. However, an 
important limitation of this study is that SHINE was orig-
inally designed to assess the effects of IYCF and WASH 
interventions on stunting and anaemia, and was powered 
to evaluate these outcomes in HIV- unexposed children; 
the ECD component was a substudy of the trial, and the 
current findings focus only on HIV- exposed children. 
Further studies are needed to confirm our findings in 
other populations.
In summary, HIV- exposed children randomised to a 
combined intervention of improved ICYF and improved 
WASH had significant improvements in ECD at 2 years 
of age, while those receiving either the IYCF or WASH 
intervention alone had no evidence of ECD benefit. 
Importantly, combining the IYCF and WASH interven-
tions closed the developmental gap between HEU and 
HIV- unexposed children. Although the mechanisms that 
underlie the synergistic effects of IYCF and WASH on 
ECD in HIV- exposed children remain unclear, our study 
implicates nutrition and WASH as contributing factors in 
the neurocognitive development of children exposed to 
HIV in early life that warrant further study. Thus, despite 
having poorer health outcomes than HIV- unexposed 
children in the absence of any interventions, we suggest 
from the results of this study, that HEU children may 
be more responsive to public health interventions. The 
interventions we provided combined WASH improve-
ments with nutritional support, which goes beyond 
what current PMTCT programmes provide. Combining 
these approaches with specific nurturing care and early 
education interventions, in line with the Nurturing 
Care Framework strategy, may bring additional bene-
fits to improve human capital in this expanding global 
population.
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